Public Health Emergency - Leading a Nation Prepared
BARDA is supporting the development of Hologic Inc.’s Panther Fusion SARS-CoV-2 assay, which is based on the widely-used Panther Fusion platform. This widely-used fully-automated, sample-to-answer platform can provide initial results in less than 3 hours and process 1,000 tests in 24 hours and could deliver test results in 3 hours, greatly expanding U.S. capacity to detect the virus. To learn more, see the award announcement.
On March 16, 2020, FDA issued an Emergency Use Authorization (EUA) to allow Hologic Inc.’s Panther Fusion SARS-CoV-2 assay to be used to diagnose COVID-19.
Home | Contact Us | Accessibility | Privacy Policies | Disclaimer | HHS Viewers & Players | HHS Plain Language
Assistant Secretary for Preparedness and Response (ASPR), 200 Independence Ave., SW, Washington, DC 20201
U.S. Department of Health and Human Services | USA.gov |
HealthCare.gov in Other Languages